COPENHAGEN (Reuters) -Discussions between Novo Nordisk and the Novo Nordisk Foundation that controls the company regarding a CEO change have been ongoing for the past few weeks, the company’s board Chair Helge Lund told Reuters on Friday. Meanwhile, outgoing Chief Executive Lars Fruergaard Jorgensen told Danish broadcaster TV2 that he was surprised by the decision, […]
Health
Talks to replace Novo Nordisk CEO lasted several weeks, board chair says
Audio By Carbonatix
COPENHAGEN (Reuters) -Discussions between Novo Nordisk and the Novo Nordisk Foundation that controls the company regarding a CEO change have been ongoing for the past few weeks, the company’s board Chair Helge Lund told Reuters on Friday.
Meanwhile, outgoing Chief Executive Lars Fruergaard Jorgensen told Danish broadcaster TV2 that he was surprised by the decision, and that he had only been informed “very recently”.
“I did not see this coming,” Fruergaard Jorgensen told TV2.
(Reporting by Maggie Fick in London, writing by Louise Breusch Rasmussen, editing by Terje Solsvik)